Sumitomo Mitsui Trust Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-39,073
Closed -$799K – 1028
2019
Q1
$799K Sell
39,073
-15,818
-29% -$275K ﹤0.01% 860
2018
Q4
$666K Buy
+54,891
New +$818K ﹤0.01% 848

Other funds holding NEO

Sumitomo Mitsui Trust Group's NEO Position: Q2 2019 in Review

Sumitomo Mitsui Trust Group sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 39,073 shares — an estimated $799K sold.

Sumitomo Mitsui Trust Group first reported a position in NEO in Q4 2018 and held it in 2 quarters. The position peaked at $799K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.

  • Sumitomo Mitsui Trust Group reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 39,073 NeoGenomics shares in Q2 2019, an estimated $799K.
  • Sumitomo Mitsui Trust Group first reported a position in NeoGenomics in Q4 2018 and held it in 2 quarters.
  • Sumitomo Mitsui Trust Group's NeoGenomics position peaked at $799K in Q1 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2019, filed 29 Jul 2019.